Clinical trial
Immune Response to the COVID-19 Vaccine
NCT04936997 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immune Response to the COVID-19 Vaccine
- Lead sponsor
- University of Arizona
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 7, 2021
- Completion date
- May 8, 2022
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, covid19, malignancy, vaccine response impaired